Conceptio › Archive › HAL (France)
HAL (France)open access

Tislelizumab efficacy and safety compared to other anti–PD-1s: a network meta-analysis of first-line therapies for unresectable, locally advanced or metastatic esophageal squamous cell carcinoma

Jaffer Ajani et al.
HAL (France) · Papers · License: Open Access
Open Source ↗
esophageal-squamous-cell-carcinomanetwork-meta-analysissystematic-literature-review
Immunotherapies, Tislelizumab, 1, Indirect treatment comparison, Systematic literature review, 0, Network meta-analysis, Esophageal squamous cell carcinoma
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 159320
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.